AngioDynamics Inc (ANGO)

12.94 +3.54 (+37.66%) USD  |  NASDAQ  |  Jan 08, 16:00
12.98 +0.04 (+0.31%) After-Hours: 20:00
More

AngioDynamics SG&A Expense (Quarterly): 35.98M for Nov. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ANGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Globus Medical Inc 240.74M
Masimo Corp 184.80M
Perspective Therapeutics Inc 6.975M
Xtant Medical Holdings Inc 19.38M
Catheter Precision Inc 2.882M